6533b7d2fe1ef96bd125e807

RESEARCH PRODUCT

PROGNOSTIC FACTORS AND RISK GROUPS IN T1G3 PATIENTS INITIALLY TREATED WITH BCG: RESULTS OF A MULTICENTER RETROSPECTIVE SERIES IN 2530 PATIENTS

F. PisanoP. GonteroR. R. SylvesterJ. JoniauK. Van Der EecktV. SerrettaS. LarrèS. Di StasiB. Van RhijnJ. WitjesA. GrotenhuisR. ColomboA. BrigantiB. BabjukV. SoukupP. MalmstromJ. Irani

subject

Bladder Cancer T1G3 BCGSettore MED/24 - Urologiahttp://hdl.handle.net/10447/84945